Enovix (ENVX) posted a third-quarter non-GAAP loss of $0.15 per share. That matched the consensus estimate but fell short of the -$0.13 Earnings Whisper number, a 15.4% miss. The loss also widened 7.1% from the -$0.14 posted a year earlier. Revenue of $11.04 million rose 38.2% and edged past the $11.0 million consensus by 0.4%, the sixth straight quarter of year-over-year growth. The quarter's numbers, however, were secondary to the strategic reset around them. New leadership effectively abandoned the near-term smartphone thesis that anchored the last three calls. It rebuilt the investment case around Korean drone and defense batteries and issued first-ever fiscal 2027 revenue guidance of $65 million to $85 million, roughly double the expected 2026 total.

The quality of the quarter is mixed. Non-GAAP gross margin jumped to a record 34.5%, up from 21.0% a year ago and 19.9% in the second quarter. Management attributed the gain to a richer mix of smart eyewear and drone/defense revenue, not to structural cost improvement. The release itself flags the ability to sustain recent margins as mix shifts as a risk, which makes the margin swing look volatile rather than durable. Below gross profit, little improved:

• Non-GAAP operating expenses rose to $33.0 million from $31.5 million.
• Non-GAAP SG&A climbed to $11.2 million from $9.5 million.
• Free cash flow worsened to -$33.1 million from -$28.5 million.

The GAAP loss narrowed to $0.19 from $0.27, but that improvement came mostly from lower stock compensation and the absence of last year's warrant-related interest charge. There is also a minor data conflict. The call analysis cites $11.25 million of revenue, while the release reports $11.04 million, the figure used here.

The call made the growth story more credible on the demand side. The Korea drone, defense and industrial pipeline grew to $216 million from $183 million in the second quarter, $130 million in the first and roughly $100 million at the end of fiscal 2025. More importantly, the pipeline is beginning to convert:

• a 100,000-battery order for conventional cells shipping in January 2027;
• a first production order for the MX1-B01 high-energy drone cell, which has been sampled to more than 30 aerial drone accounts;
• $37 million of backlog, nearly half the 2027 guidance midpoint.

A $19 million expansion to double Korean drone capacity is due online in the second quarter of 2027. That is a faster timeline than the mid-2027 ramp discussed in August. Management struck a markedly more aggressive tone, expecting to be capacity-constrained in 2027.

The cost of that pivot is substantial. CEO Raj Talluri is gone, leaving an interim CEO and a hands-on Executive Chairman, T.J. Rodgers, in charge. AI-1 passed internal qualification, and the lead smartphone customer's parallel testing was expected to finish shortly after the report. Even so, management declined to proceed with field testing because the cells missed the 1,000-plus Wh/L energy-density target, and it now assumes nominal smartphone revenue in 2027. Other risks also surfaced:

• R&D projects were cut from 19 to 8 alongside a 220-position reduction, which could slow the technology roadmap.
• Malaysia Fab2 sits underutilized.
• Management said break-even requires roughly four times the 2027 revenue run-rate.

The near term is also soft. Fourth-quarter revenue guidance of $9 million to $10 million implies both a sequential decline and a 12% to 20% year-over-year drop, with the loss guided roughly flat.

The balance-sheet maneuvering cuts both ways. Retiring $128 million of 2030 notes for about $81 million captured a meaningful discount, and that discount will flow through GAAP results as a gain. However, cash fell to roughly $415 million after the debt actions, down from $552 million in the second quarter. The warrant dividend meant to retire the 2028 notes carries a $3.00 strike, above the $2.53 share price heading into the report. Its success depends on the stock recovering and could bring dilution if it does.

The market had already priced in deep skepticism. Shares fell 45.6% from the open after the August report to $2.53 and sit about 49% below the $4.97 200-day moving average. They touched a 52-week low of $2.19 on November 5 and remain only 15.5% above it. Investor sentiment stayed negative and weakened modestly into the print, slipping from -0.46 to -0.52. The Earnings Whispers trend readings are mixed: sequential growth and momentum are positive, while AVWAP remains negative.

The bottom line is that Enovix traded a long-dated smartphone option for a nearer-term, order-backed drone and defense business. The 2027 guidance, backlog and capacity expansion give the new strategy real substance. Still, the third quarter itself delivered a whisper miss, a wider non-GAAP loss, rising cash burn and a declining fourth-quarter outlook. Bears have legitimate ammunition in the leadership upheaval, the shrinking cash pile and the distance to break-even. The burden is now on 2027 execution in Korea to prove that the record margin and the pipeline growth translate into sustainable revenue.